arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Core Scientific, Inc./tx

CORZ
$11.40 ▼ -1.35 (-10.59%) at close
Financials ·Finance Services ·USFinance Services
24 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
46
Health
Weak
Neutral
auto_awesome

Analytical Summary

Core Scientific, Inc./tx shows mixed fundamentals. On the positive side, Return on Common Equity (%) remains strong. Consider comparing against peers in the Financials sector before making investment decisions.

Market Cap $3.7B
Dividend Yield —
Revenue Growth 108.8% ↗
Op. Margin -47.8% ↗
ROIC -4.2% ↘
FCF / Share $-1.79 ↘
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity -1.78
info Valuation on last close. End-of-day price, Nov 5, 2026.

24-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$164.20M
↑ +108.8% —
Net Income Profit after all expenses
$-1.16B
↓ -23.3% —
Operating Margin Operating profit as % of sales
-47.8%
↑ +82.3% 3th
FCF / Share Free cash flow per share
$-1.79
↓ -554.0% —
Long-Term Debt Long-term obligations
$4.30B
↑ +304.8% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
3
Returns
92
Financial Health
26
Cash Quality
81

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 24 quarters